Serum adenosine deaminase 2 predicts chemotherapy response and survival in advanced high-grade serous ovarian carcinoma
Year: 2026
Type: article
Study design: Observational Study
Source: Gynecologic Oncology
Authors: Collin Sitler, Kathleen Darcy, Tamara Abulez, Chunqiao Tian, Samantha Streich, Megan Allen, Ahmed Hussain, Christopher Tarney, Ming Zhou, Brian Hood, Katlin Wilson, Kelly Conrads, Taylor Deskins, Leslie Randall, Laura Havrilesky, Casey Cosgrove, Linda Duska, Christina Washington, Kathleen Moore, Neil Phippen, Nicholas Bateman, Thomas Conrads, George Maxwell
Institutions: Womack Army Medical Center, Duke Cancer Institute, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, University of Virginia Medical Center, University of Oklahoma Health Sciences Center
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7128915419